Bone marrow-derived AXL tyrosine kinase promotes mitogenic crosstalk and cardiac allograft vasculopathy
Wasserstrom, J Andrew
Ansari, Mohammed Javeed
Zhang, Zheng Jenny
Leventhal, Joseph R
Forbess, Joseph M
Thorp, Edward B
JournalJournal of heart and lung transplantation
MetadataShow full item record
AbstractCardiac Allograft Vasculopathy (CAV) is a leading contributor to late transplant rejection. Although implicated, the mechanisms by which bone marrow-derived cells promote CAV remain unclear. Emerging evidence implicates the cell surface receptor tyrosine kinase AXL to be elevated in rejecting human allografts. AXL protein is found on multiple cell types, including bone marrow-derived myeloid cells. The causal role of AXL from this compartment and during transplant is largely unknown. This is important because AXL is a key regulator of myeloid inflammation. Utilizing experimental chimeras deficient in the bone marrow-derived Axl gene, we report that Axl antagonizes cardiac allograft survival and promotes CAV. Flow cytometric and histologic analyses of Axl-deficient transplant recipients revealed reductions in both allograft immune cell accumulation and vascular intimal thickness. Co-culture experiments designed to identify cell-intrinsic functions of Axl uncovered complementary cell-proliferative pathways by which Axl promotes CAV-associated inflammation. Specifically, Axl-deficient myeloid cells were less efficient at increasing the replication of both antigen-specific T cells and vascular smooth muscle cells (VSMCs), the latter a key hallmark of CAV. For the latter, we discovered that Axl-was required to amass the VSMC mitogen Platelet-Derived Growth Factor. Taken together, our studies reveal a new role for myeloid Axl in the progression of CAV and mitogenic crosstalk. Inhibition of AXL-protein, in combination with current standards of care, is a candidate strategy to prolong cardiac allograft survival. © 2021 International Society for Heart and Lung Transplantation
Rights/TermsCopyright © 2021 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
KeywordAxl tyrosine kinase
cardiac allograft vasculopathy
vascular smooth muscle cell
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/15447
- Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
- Authors: Ardehali A, Laks H, Drinkwater DC, Ziv E, Drake TA
- Issue date: 1995 Aug 1
- Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
- Authors: Koglin J
- Issue date: 2000
- Association of Intimal Neovessels Noted by Optical Coherence Tomography with Cardiac Allograft Vasculopathy.
- Authors: Chahal DS, Parikh R, Yoo D, Aje T, Ramani G, Srivastava MC
- Issue date: 2020 Mar 29
- CD34+CD140b+ cells and circulating CXCL12 correlate with the angiographically assessed severity of cardiac allograft vasculopathy.
- Authors: Schober A, Hristov M, Kofler S, Forbrig R, Löhr B, Heussen N, Zhe Z, Akhtar S, Schumann U, Krötz F, Leibig M, König A, Kaczmarek I, Reichart B, Klauss V, Weber C, Sohn HY
- Issue date: 2011 Feb
- Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
- Authors: Zhao DX, Hu Y, Miller GG, Luster AD, Mitchell RN, Libby P
- Issue date: 2002 Aug 1